Drax Exametazime

Jubilant DraxImage Inc., dba Jubilant Radiopharma🇺🇸 United States

FDA Page

Effective Date: Nov 8, 2022
Approval ID: fa7811f9-2803-4126-8037-8f3e56462f9c
Products: 1 registered
Version: 3

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use Drax Exametazime safely and effectively. See full prescribing information for Drax Exametazime. Drax Exametazime (kit for the preparation of technetium Tc 99m exametazime for leukocyte labeling) for intravenous use.Initial U.S. Approval: 1988

Quick Stats

Total Products1

Labelers2

Label Sections28

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.